Lunds Melanomstudiegrupp

Forskningsoutput

Forskningsoutput per år 1980 2017 2019 2020 2021 2022 2023 2024 2024

• 211 Artikel i vetenskaplig tidskrift
• 18 Doktorsavhandling (sammanläggning)
• 6 Letter
• 4 Översiktsartikel
• 11 Mer
  • 3 Debate/Note/Editorial
  • 2 Kapitel samlingsverk
  • 2 Konferensabstract
  • 2 Artikel i facktidskrift eller populärpress
  • 1 Konferenspaper i proceeding
  • 1 Publicerat konferensabstract

Forskningsoutput per år

Forskningsoutput per år

Sökresultat

• 2024

  Assessment of image quality on the diagnostic performance of clinicians and deep learning models: Cross-sectional comparative reader study

  Oloruntoba, A. I., Asghari-Jafarabadi, M., Sashindranath, M., Ingvar, Å., Adler, N. R., Vico-Alonso, C., Niklasson, L., Caixinha, A. L., Hiscutt, E., Holmes, Z., Assersen, K. B., Adamson, S., Jegathees, T., Bertelsen, T., Velasco-Tamariz, V., Helkkula, T., Kristiansen, S., Toholka, R., Goh, M. S. & Chamberlain, A. & 7 andra, McCormack, C., Vestergaard, T., Mehta, D., Nguyen, T. D., Ge, Z., Soyer, H. P. & Mar, V., 2024 dec. 10, (E-pub ahead of print) I: Journal of the European Academy of Dermatology and Venereology : JEADV.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

  Godina, C., Belting, M., Vallon-Christersson, J., Isaksson, K., Bosch, A. & Jernström, H., 2024 dec., I: Scientific Reports. 14, 1, 6675.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Breast Cancer 100%
  • Tumor Microenvironment 20%
  • Patient 6%
  • Cells 6%
  • Therapeutics 6%

• Molecular patterns of resistance to immune checkpoint blockade in melanoma

  Lauss, M., Phung, B., Borch, T. H., Harbst, K., Kaminska, K., Ebbesson, A., Hedenfalk, I., Yuan, J., Nielsen, K., Ingvar, C., Carneiro, A., Isaksson, K., Pietras, K., Svane, I. M., Donia, M. & Jönsson, G., 2024 dec., I: Nature Communications. 15, 1, 3075.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Nodular Melanoma 100%
  • Immune Checkpoint Blockade 100%
  • Immune Checkpoints 100%
  • Patient 33%
  • Therapeutic Procedure 33%

• Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells

  Roostee, S., Ehinger, D., Jönsson, M., Phung, B., Jönsson, G., Sjödahl, G., Staaf, J. & Aine, M., 2024 dec., I: Scientific Reports. 14, 1, 21417.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

• Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study

  Sun, M., da Silva, M., Bjørge, T., Fritz, J., Mboya, I. B., Jerkeman, M., Stattin, P., Wahlström, J., Michaëlsson, K., van Guelpen, B., Magnusson, P. K. E., Sandin, S., Yin, W., Lagerros, Y. T., Ye, W., Nwaru, B., Kankaanranta, H., Lönnberg, L., Chabok, A. & Isaksson, K. & 6 andra, Pedersen, N. L., Elmståhl, S., Lind, L., Hedman, L., Häggström, C. & Stocks, T., 2024 okt., I: The Lancet regional health. Europe. 45, 101034.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Small Intestine Cancer 100%
  • Abdominal Cancer 100%

• Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants

  Wadt, K. A. W., Harbst, K., Sjøl, M. M. B., Rosengren, F., Yde, C. W., Rohrberg, K. S., Jensen, M. R., Heegaard, S., Kiilgaard, J. F., Gerdes, A. M., Hayward, N. K. & Jönsson, G. B., 2024 okt., I: PLoS ONE. 19, 10, e0306386.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

• Interobserver agreement on line-field confocal optical coherence tomography image markers in keratinocyte carcinomas and precursor lesions

  Jacobsen, K., Ortner, V. K., Wenande, E., Fredman, G., Untracht, G. R., Wolswijk, T., Cruts, E., Mosterd, K., Nielsen, K., Philipsen, P. A., Wiegell, S. R. & Haedersdal, M., 2024 sep. 6, I: Archives of Dermatological Research. 316, 608.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Lesion 100%
  • Precursor 100%
  • Carcinoma 100%
  • Association 20%
  • Squamous Cell Carcinoma 20%

• Acral Melanoma Incidence and Survival Trends in 1990–2020: A Nationwide, Population-based Study

  Helkkula, T., Christensen, G., Mikiver, R., Ingvar, Å., Isaksson, K. & Nielsen, K., 2024 aug. 14, I: Acta Dermato-Venereologica. 104

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Nodular Melanoma 100%
  • Male 30%
  • Survival Rate 23%
  • Female 23%
  • Patient 15%

• Cohort profile: The Obesity and Disease Development Sweden (ODDS) study, a pooled cohort

  da Silva, M., Fritz, J., Mboya, I. B., Sun, M., Wahlström, J., van Guelpen, B., Michaëlsson, K., Magnusson, P. K. E., Melander, O., Sandin, S., Yin, W., Trolle Lagerros, Y., Nwaru, B., Leppert, J., Chabok, A., Pedersen, N. L., Elmståhl, S., Isaksson, K., Ingvar, C. & Hedman, L. & 3 andra, Backman, H., Häggström, C. & Stocks, T., 2024 juli 16, I: BMJ Open. 14, 7, e084836.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Man 100%
  • Information 100%
  • Woman 66%
  • Weight 66%
  • Follow up 55%

• High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

  Godina, C., Khazaei, S., Belting, M., Vallon-Christersson, J., Nodin, B., Jirström, K., Isaksson, K., Bosch, A. & Jernström, H., 2024 juli 3, I: PLoS ONE. 19, 7, s. 1-21 e0305222.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Caveolin 1 100%
  • Messenger RNA 100%
  • Protein 15%
  • Mesenchymal-Epithelial Transition 15%
  • Immune Response 7%

• The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study

  Kappelin, J., Ahnlide, I., Ingvar, Å. & Nielsen, K., 2024 maj 27, I: Acta Dermato-Venereologica. 104, adv40112.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Basal-Cell Carcinoma 100%
  • Male 18%
  • Development 9%
  • Age 9%
  • Cancer Types 9%

• The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study

  Huss, L., Gulz-Haake, I., Nilsson, E., Tryggvadottir, H., Nilsson, L., Nodin, B., Jirström, K., Isaksson, K. & Jernström, H., 2024 mars 23, I: Nutrients. 16, 7, s. 1-15 931.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Breast Cancer 100%
  • Cohort Analysis 100%
  • Eicosanoid Receptor 100%
  • Cohort Study 100%
  • Overall Survival 42%

• BioMEL: a translational research biobank of melanocytic lesions and melanoma

  Helkkula, T., Christensen, G., Ingvar, C., Isaksson, K., Harbst, K., Persson, B., Ingvar, Hafström, A., Carneiro, A., Gaspar, V., Jönsson, G. & Nielsen, K., 2024 feb., I: BMJ Open. 14, 2, e069694.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Lesion 100%
  • Translational Research 100%
  • Nodular Melanoma 100%
  • Nevus Sebaceous 50%
  • Patient 25%

• A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor

  Faraj Tabrizi, S., Mei, W., Godina, C., Lovisa, A. F., Isaksson, K., Jernström, H. & Tavazoie, S. F., 2024, (E-pub ahead of print) I: Cell. s. 1-19; e1-e15

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Cancer cells impair monocyte-mediated T cell stimulation to evade immunity

  Elewaut, A., Estivill, G., Bayerl, F., Castillon, L., Novatchkova, M., Pottendorfer, E., Hoffmann-Haas, L., Schönlein, M., Nguyen, T. V., Lauss, M., Andreatta, F., Vulin, M., Krecioch, I., Bayerl, J., Pedde, A. M., Fabre, N., Holstein, F., Cronin, S. M., Rieser, S. & Laniti, D. D. & 11 andra, Barras, D., Coukos, G., Quek, C., Bai, X., Muñoz i Ordoño, M., Wiesner, T., Zuber, J., Jönsson, G., Böttcher, J. P., Vanharanta, S. & Obenauf, A. C., 2024, (Accepted/In press) I: Nature.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

• Cost of Illness of Head and Neck Cancer in Sweden

  Silfverschiöld, M., Jarl, J., Hafström, A., Greiff, L. & Sjövall, J., 2024, I: Value in Health. 27, 4, s. 425-432

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Sweden 100%
  • Productivity 100%
  • Loss 100%
  • Health Care Cost 100%
  • Head and Neck Cancer 100%

• Melanoma Incidence and Mortality Trends in Sweden

  Helgadottir, H., Mikiver, R., Schultz, K., Nielsen, K., Portelli, F., Lapins, J., Puig, S. & Isaksson, K., 2024, I: JAMA Dermatology. 160, 11, 1201.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Mortality 100%
  • Melanoma 100%
  • Age Groups 36%
  • Cutaneous Melanoma 27%
  • Patient 18%

• Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status

  Bagge, R. O., Mikiver, R., Marchetti, M. A., Lo, S. N., Van Akkooi, A. C. J., Coit, D. G., Ingvar, C., Isaksson, K., Scolyer, R. A., Thompson, J. F., Varey, A. H. R., Wong, S. L., Lyth, J. & Bartlett, E. K., 2024, I: JAMA Surgery. 159, 3, 260.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Nodular Melanoma 100%
  • Cancer Center 100%
  • Sentinel Lymph Node Biopsy 66%
  • Age 8%

• Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study

  Lindgren, H., Ademi, D., Godina, C., Tryggvadottir, H., Isaksson, K. & Jernström, H., 2024, I: Cancer Causes and Control. 35, 6, s. 907-919

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Eicosanoid Receptor 100%
  • Prospective Cohort Study 100%
  • Genotyping 33%
  • Genotype 33%
  • Survival 16%

• Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients

  Nilsson, L., Khazaei, S., Tryggvadottir, H., Björner, S., Bressan, A., Jirström, K., Adrian, G., Falck, A.-K., Borgquist, S., Isaksson, K. & Jernström, H., 2024, I: Clinical Breast Cancer. 24, 3, s. e152-e166

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Breast Cancer 100%
  • Aryl Hydrocarbon Receptor 100%
  • Antioxidant 100%
  • Prognosis 33%

• Teledermoscopic triage of melanoma-suspicious skin lesions is safe: A retrospective comparative diagnostic accuracy study with multiple assessors

  Nervil, G. G., Ternov, N. K., Lorentzen, H., Kromann, C., Ingvar, Å., Nielsen, K., Tolsgaard, M., Vestergaard, T. & Hölmich, L. R., 2024, (Accepted/In press) I: Journal of Telemedicine and Telecare.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Time trends of the association of body mass index with mortality in 3.5 million young Swedish adults

  Mboya, I. B., Fritz, J., da Silva, M., Sun, M., Wahlström, J., Magnusson, P. K. E., Sandin, S., Yin, W., Söderberg, S., Pedersen, N. L., Lagerros, Y. T., Nwaru, B. I., Kankaanranta, H., Chabok, A., Leppert, J., Backman, H., Hedman, L., Isaksson, K., Michaëlsson, K. & Häggström, C. & 1 andra, Stocks, T., 2024, I: Annals of Epidemiology. 97, s. 23-32

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Men 100%
  • Women 75%
  • Calendar Effect 75%
  • Proportional Hazards Regression Model 56%
• 2023

  Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study

  Naeser, Y., Mikiver, R., Ingvar, C., Lambe, M. & Ullenhag, G. J., 2023 nov., I: EClinicalMedicine. 65, 102284.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Cohort Analysis 100%
  • Nodular Melanoma 100%
  • Survival 100%
  • Comorbidity 100%

• A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

  Middha, P., Wang, X., Behrens, S., Bolla, M. K., Wang, Q., Dennis, J., Michailidou, K., Ahearn, T. U., Andrulis, I. L., Anton-Culver, H., Arndt, V., Aronson, K. J., Auer, P. L., Augustinsson, A., Baert, T., Freeman, L. E. B., Becher, H., Beckmann, M. W., Benitez, J. & Bojesen, S. E. & 30 andra, Brauch, H., Brenner, H., Brooks-Wilson, A., Campa, D., Canzian, F., Carracedo, A., Castelao, J. E., Chanock, S. J., Chenevix-Trench, G., Cordina-Duverger, E., Couch, F. J., Cox, A., Cross, S. S., Czene, K., Dossus, L., Dugué, P.-A., Eliassen, A. H., Eriksson, M., Evans, D. G., Fasching, P. A., Figueroa, J. D., Fletcher, O., Flyger, H., Gabrielson, M., Gago-Dominguez, M., Hall, P., Ingvar, C., Isaksson, K., Jernström, H. & CTS Consortium, 2023 aug. 9, I: Breast cancer research : BCR. 25, 1, s. 1-13 93.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Breast Cancer 100%
  • Genotype Environment Interaction 100%
  • Woman 100%
  • Cancer Risk 100%
  • Gene-Environment Interaction 100%

• Factors for not performing total body skin examinations in primary care in association with teledermoscopy

  Ingvar, J., Nielsen, K. & Ingvar, Å., 2023 mars 21, I: BMC Primary Care. 24, 1, 76.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Association 100%
  • Primary Health Care 100%
  • Primary Medical Care 100%
  • Patient 90%
  • Physician 40%

• Association of metformin use and survival in patients with cutaneous melanoma and diabetes

  Krakowski, I., Häbel, H., Nielsen, K., Ingvar, C., Andersson, T. M. L., Girnita, A., Smedby, K. E. & Eriksson, H., 2023 jan. 23, I: The British journal of dermatology. 188, 1, s. 32-40

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Diabetes 100%
  • Glycon 100%
  • Cutaneous Melanoma 100%
  • Metformin 100%

• Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination

  Arance, A., De La Cruz-Merino, L., Petrella, T. M., Jamal, R., Ny, L., Carneiro, A., Berrocal, A., Márquez-Rodas, I., Spreafico, A., Atkinson, V., Costa Svedman, F., Mant, A., Khattak, M. A., Mihalcioiu, C., Jang, S., Cowey, C. L., Smith, A. D., Hawk, N., Chen, K. & Diede, S. J. & 2 andra, Krepler, C. & Long, G. V., 2023 jan. 1, I: Journal of Clinical Oncology. 41, 1, s. 75-85 11 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Therapeutic Procedure 100%
  • Monotherapy 100%
  • Nodular Melanoma 100%
  • Programmed Death 1 Ligand 1 100%
  • Melanoma 100%

• Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

  Mueller, S. H., Augustinsson, A., Olsson, H., NBCS Collaborators, CTS Consortium, ABCTB Investigators & Kuchenbaecker, K. B., 2023, I: Genome Medicine. 15, 1, 7.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Gene 100%
  • Candidate Gene 7%
  • Cohort Study 7%
  • Regulatory Region 7%
  • MAP3K1 7%

• Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?

  Gisslander, K., de Boer, R., Ingvar, C., Turesson, C., Isaksson, K., Jayne, D. & Mohammad, A., 2023, I: Rheumatology Advances in Practice. 7, 3

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Rheumatic Polymyalgia 100%
  • Prospective Cohort Study 28%
  • Obesity 14%
  • Melanoma 14%

• Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

  Godina, C., Tryggvadottir, H., Bosch, A., Borgquist, S., Belting, M., Isaksson, K. & Jernström, H., 2023, I: Breast Cancer Research and Treatment. 199, 2, s. 335-347 13 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Disease 100%
  • Breast Cancer 100%
  • Genotype 100%
  • Contralateral 100%
  • Patient 50%

• Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells

  Nyström, H., Jönsson, M., Nilbert, M. & Carneiro, A., 2023, I: Acta Oncologica. 62, 1, s. 33-39 7 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • B Cell 100%
  • Macrophage 100%
  • Soft Tissue Sarcoma 100%
  • Immune Cell Infiltration 100%
  • Soft Tissue 100%

• Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients

  Lyth, J., Mikiver, R., Nielsen, K., Ingvar, C., Olofsson Bagge, R. & Isaksson, K., 2023, I: European Journal of Surgical Oncology. 49, 10, 106974.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Therapeutic Procedure 100%
  • Nodular Melanoma 100%
  • Cutaneous Melanoma 25%
  • Epileptic Absence 12%

• Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)

  Holmberg, C.-J., Mikiver, R., Isaksson, K., Ingvar, C., Moncrieff, M., Nielsen, K., Ny, L., Lyth, J. & Olofsson Bagge, R., 2023, I: Annals of Surgical Oncology. 30, 13, s. 8026-8033

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Nodular Melanoma 100%
  • Patient 80%
  • Prognostic Factor 20%
  • Cutaneous Melanoma 20%
  • Sentinel Lymph Node Biopsy 10%

• South Africa and the Surgical Diaspora-A Hub for Surgical Migration and Training

  Rudolfson, N., Lantz, A., Shrime, M. G., Johnson, W., Smith, M. D. & Hagander, L., 2023, I: World Journal of Surgery. 47, 7, s. 1684-1691

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Surgeon 100%
  • Anesthesiologist 100%
  • Physician 50%
  • Low and Middle Income Countries 50%
  • Health 25%
• 2022

  Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies

  Jung, A. Y., Ahearn, T. U., Behrens, S., Middha, P., Bolla, M. K., Wang, Q., Arndt, V., Aronson, K. J., Augustinsson, A., Beane Freeman, L. E., Becher, H., Brenner, H., Canzian, F., Carey, L. A., Czene, K., Eliassen, A. H., Eriksson, M., Evans, D. G., Figueroa, J. D. & Fritschi, L. & 31 andra, Gabrielson, M., Giles, G. G., Guénel, P., Hadjisavvas, A., Haiman, C. A., Håkansson, N., Hall, P., Hamann, U., Hoppe, R., Hopper, J. L., Howell, A., Hunter, D. J., Hüsing, A., Kaaks, R., Kosma, V.-M., Koutros, S., Kraft, P., Lacey, J. V., Le Marchand, L., Lissowska, J., Loizidou, M. A., Mannermaa, A., Maurer, T., Murphy, R. A., Olshan, A. F., Olsson, H., Patel, A. V., Perou, C. M., Rennert, G., Shibli, R. & CTS Consortium, 2022 dec. 8, I: Journal of the National Cancer Institute. 114, 12, s. 1706-1719 14 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Childbirth 100%
  • Breast Cancer 100%
  • Woman 100%
  • Pooled Analysis 100%
  • Birth 100%

• DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype

  Sanna, A., Phung, B., Mitra, S., Lauss, M., Choi, J., Zhang, T., Njauw, C.-N. J., Cordero, E., Harbst, K., Rosengren, F., Cabrita, R., Johansson, I., Isaksson, K., Ingvar, C., Carneiro, A., Brown, K., Tsao, H., Andersson, M., Pietras, K. & Jönsson, G., 2022 okt. 10, I: JCI Insight. 7, 19, e156577.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Gene 100%
  • Phenotype 100%
  • Microphthalmia-Associated Transcription Factor 100%
  • Melanocyte 100%
  • Survival 20%

• Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

  Godina, C., Indira Chandran, V., Barbachowska, M., Tryggvadottir, H., Nodin, B., Visse, E., Borgquist, S., Jirström, K., Isaksson, K., Bosch, A., Belting, M. & Jernström, H., 2022 aug., I: Translational Oncology. 22, 101464.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Breast Cancer 100%
  • Caveolin 1 100%
  • Patient 28%
  • Recurrence Risk 28%
  • Disease 14%

• Immediate increase in perceived energy after exercise during the course of chemotherapy treatment for breast cancer

  Johnsson, A., Sjovall, K., Demmelmaier, I., Wagner, P., Olsson, H. & Tornberg, Å., 2022 maj 28, I: European Journal of Oncology Nursing. 58, 102149.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Woman 66%
  • Visual Analog Scale 33%
  • Clinician 33%
  • Motivation 29%

• Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)

  Naeser, Y., Helgadottir, H., Hansson, J., Ingvar, C., Elander, N. O., Flygare, P., Nilsson, C., Jakobsson, F., Valachis, A., Papantoniou, D., Danfors, A. N., Johansson, H., Sundin, A., Brandberg, Y. & Ullenhag, G. J., 2022 feb., I: Cancers. 14, 4, 1040.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Follow up 100%
  • Cutaneous Melanoma 100%
  • Radical Surgery 100%
  • Quality of Life 100%

• Neoantigen-reactive CD8⁺ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma

  Kristensen, N. P., Heeke, C., Tvingsholm, S. A., Borch, A., Draghi, A., Crowther, M. D., Carri, I., Munk, K. K., Holm, J. S., Bjerregaard, A. M., Bentzen, A. K., Marquard, A. M., Szallasi, Z., McGranahan, N., Andersen, R., Nielsen, M., Jönsson, G. B., Donia, M., Svane, I. M. & Hadrup, S. R., 2022 jan., I: Journal of Clinical Investigation. 132, 2, 150535.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cytotoxic T-Cell 100%
  • Neoantigen 100%
  • Tumor-Infiltrating Lymphocytes 100%
  • Recognition 22%
  • Clearance 11%

• Copy number variants are ovarian cancer risk alleles at known and novel risk loci

  Devries, A. A., Olsson, H., Jones, M. R. & et al., 2022, I: Journal of the National Cancer Institute. 114, 11, s. 1533-1544 12 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cancer Risk 100%
  • Ovarian Cancer 100%
  • Krukenberg Tumor 100%
  • RAD51C 33%
  • Cells 14%

• Incidence and trends of basal cell carcinoma in Sweden: A population-based registry study

  Kappelin, J., Green, A. C., Ingvar, Å., Ahnlide, I. & Nielsen, K., 2022, I: The British journal of dermatology. 186, 6, s. 963-969

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Basal-Cell Carcinoma 100%
  • Woman 18%
  • Patient 9%
  • Man 9%
  • Age 9%

• Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

  Dixon-Suen, S. C., Augustinsson, A., Olsson, H., Lynch, B. M. & Breast Cancer Association Consortium, 2022, I: British journal of sports medicine. 56, 20, s. 1157-1170

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Breast Cancer 100%
  • Cancer Risk 100%
  • Mendelian Randomization Analysis 100%
  • Confidence Interval 100%
  • Variance 33%

• Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial

  Crystal, J. S., Ingvar, C., Faries, M. B. & Multicenter Selective Lymphadenectomy Trials Study Group, 2022, I: JAMA Surgery. 157, 9, s. 835-842 8 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Patient 100%
  • Therapeutics 100%
  • Sentinel Lymph Node Biopsy 100%
  • Nodular Melanoma 100%
  • Randomized Clinical Trial 100%

• Transcriptomic signatures of tumors undergoing T cell attack

  Gokuldass, A., Schina, A., Lauss, M., Harbst, K., Chamberlain, C. A., Draghi, A., Westergaard, M. C. W., Nielsen, M., Papp, K., Sztupinszki, Z., Csabai, I., Svane, I. M., Szallasi, Z., Jönsson, G. & Donia, M., 2022, I: Cancer Immunology, Immunotherapy. 71, 3, s. 553-563

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • T Cell 100%
  • Tumor-Infiltrating Lymphocytes 40%
  • Recognition 20%
  • Cancer Immunotherapy 20%
  • Programmed Death-Ligand 1 20%
• 2021

  PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma

  Vidarsdottir, L., Azimi, A., Das, I., Sigvaldadottir, I., Suryo Rahmanto, A., Petri, A., Kauppinen, S., Ingvar, C., Jönsson, G., Olsson, H., Frostvik Stolt, M., Tuominen, R., Sangfelt, O., Pokrovskaja Tamm, K., Hansson, J., Grandér, D., Egyházi Brage, S. & Johnsson, P., 2021 dec. 1, I: Scientific Reports. 11, 1, 11023.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Melanoma 100%
  • Complementary RNA 20%
  • Transcription 16%
  • EZH2 16%
  • Pseudogene 16%

• Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families

  Lacson, J. C. A., Zamani, S. A., Froes, L. A. R., Mitra, N., Qian, L., Doyle, S. H., Azizi, E., Balestrini, C., Bishop, D. T., Bruno, W., Carlos-Ortega, B., Cuellar, F., Cust, A. E., Elder, D. E., Gerdes, A. M., Ghiorzo, P., Grazziotin, T. C., Gruis, N. A., Hansson, J. & Hočevar, M. & 19 andra, Höiom, V., Holland, E. A., Ingvar, C., Landman, G., Larre-Borges, A., Mann, G. J., Molgo, M., Moredo, L. F., Olsson, H., Out-Luiting, J. J., Perić, B., Pjanova, D., Puig, S., Salas-Alanis, J., Schmid, H., Wadt, K. A. W., Newton-Bishop, J. A., Kanetsky, P. A. & GenoMEL Study Group, 2021 dec., I: BMC Public Health. 21, 1, 692.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Childbirth 100%
  • Family 100%
  • Nodular Melanoma 100%
  • Sunburn 50%
  • Association 12%

• St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study

  Narbe, U., Bendahl, P. O., Fernö, M., Ingvar, C., Dihge, L. & Rydén, L., 2021 dec., I: The British journal of surgery. 108, 12, s. 1465-1473 9 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient 100%
  • Breast Cancer 100%
  • Axilla 100%
  • Axillary Lymph Node 77%
  • Retroperitoneal Lymph Node Dissection 44%

• Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: A prospective cohort study

  Godina, C., Khazaei, S., Tryggvadottir, H., Visse, E., Nodin, B., Jirström, K., Borgquist, S., Bosch, A., Isaksson, K. & Jernström, H., 2021 nov. 1, I: Carcinogenesis. 42, 11, s. 1314-1325 12 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Breast Cancer 100%
  • Prospective Cohort Study 100%
  • Specific Tumor 100%
  • Somatomedin 100%
  • Protein Binding 100%

• Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens

  Draghi, A., Chamberlain, C. A., Khan, S., Papp, K., Lauss, M., Soraggi, S., Radic, H. D., Presti, M., Harbst, K., Gokuldass, A., Kverneland, A., Nielsen, M., Westergaard, M. C. W., Andersen, M. H., Csabai, I., Jönsson, G., Szallasi, Z., Svane, I. M. & Donia, M., 2021 okt. 11, I: Frontiers in Immunology. 12, 705422.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Recognition 100%
  • Tumor Antigen 100%
  • Tumor Necrosis Factor 100%
  • Tumor-Infiltrating Lymphocytes 100%
  • CD8 42%